Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa)

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 1, 1998, Pages 354-361

  Zhang, Lei ^a   Schaner, Marci E ^a   Giacomini, Kathleen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; CATION TRANSPORT; DRUG RECEPTOR BINDING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARRIER PROTEINS; CORTICOSTERONE; HELA CELLS; HUMANS; MEMBRANE PROTEINS; MIDAZOLAM; ORGANIC CATION TRANSPORTER 1; PERMEABILITY; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAETHYLAMMONIUM COMPOUNDS; TRANSFECTION;

EID: 0031846917     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Blaschke TF and Giacomini KM (1987) "Pharmacodynamic consequences of enantioselective drug disposition," in Pharmacology (Rand MJ and Raper C, eds) Elsevier Science, Amsterdam.
2. Bossuyt X, Muller M, Hagenbuch B and Meier PJ (1996) Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver. J Pharmacol Exp Ther 276:891-896.
3. + bile acid cotransport system in COS-7 cells. Am J Physiol 266:G382-G387.
4. Busch AE, Quester S, Ulzheimer JC, Waldegger S, Gorboulev V, Arndt P, Lang F and Koepsell H (1996) Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1. J Biol Chem 271:32599-32604.
5. Cardarelli CO, Aksentijevich I, Pastan I and Gottesman MM (1995) Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters. Cancer Res 55:1086-1091.
6. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
7. Clark JA and Amara SG (1994) Stable expression of a neuronal gamma-aminobutyric acid transporter, GAT-3, in mammalian cells demonstrates unique pharmacological properties and ion dependence. Mol Pharmacol 46:550-557.
8. Drayer DE (1986) Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: an overview. Clin Pharmacol Ther 40:125-133.
9. Giacomini KM, Markovich D, Werner A, Biber J, Wu X and Murer H (1994) Expression of a renal Na(+)-nucleoside cotransport system (N2) in Xenopus laevis oocytes. Pflugers Arch 427:381-383.
10. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, Baumann C, Lang F, Busch AE and Koepsell H (1997) Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 16:871-881.
11. Groves CE, Morales MN, Gandolfi AJ, Dantzler WH and Wright SH (1995) Peritubular paraquat transport in isolated renal proximal tubules. J Pharmacol Exp Ther 275:926-932.
12. 1 cells. J Biol Chem 272:10408-10413.
13. Grundemann D, Gorboulev V, Gambaryan S, Veyhl M and Koepsell H (1994) Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372: 549-552.
14. Hawley-Nelson P, Ciccarone V, Gebeyehu G, Jessee J and Felgner PL (1993) LipofectAMINE regent: a new, higher efficiency polycationic liposome transfection reagent. Focus 15:73-9.
15. Ikumi T, Yabuuchi H, Nezu J, Sai Y, Oku A, Shimane M and Tsuji A (1997) Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419:107-111.
16. Kanai N, Lu R, Bao Y, Wolkoff AW and Schuster VL (1996) Transient expression of oatp organic anion transporter in mammalian cells: identification of candidate substrates. Am J Physiol 270:F319-F325.
17. Levy RH and Boddy AV (1991) Stereoselectivity in pharmacokinetics: A general theory. Pharm Res 8:551-556.
18. Martel F, Vetter T, Russ H, Grundemann D, Azevedo I, Koepsell H and Schomig E (1996) Transport of amall organic cations in the rat liver. The role of the organic cation transporter OCT1. Naunyn Schmiede bergs Arch Pharmacol 354:320-326.
19. i) reabsorption and of its regulation. Pflugers Arch 433:379-389.
20. Nagel G, Volk C, Friedrich T, Ulzheimer JC, Bamberg E and Koepsell H (1997) A reevaluation of substrate specificity of the rat cation transporter rOCT1. J Biol Chem 272:31953-31956.
21. Okuda M, Saito H, Urakami Y, Takano M and Inui K (1996) cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem Biophys Res Commun 224:500-507.
22. Pritchard JB and Miller DS (1993) Mechanisms mediating renal secretion of organic anions and cations. Physiol Rev 73:765-796.
23. Risso S, DeFelice LJ and Blakely RD (1996) Sodium-dependent GABA-induced currents in GAT1-transfected HeLa cells. J Physiol (Lond) 490:691-702.
24. Sandker GW, Weert B, Olinga P, Wolters H, Slooff MJ, Meijer DK and Groothuis GM (1994) Characterization of transport in isolated human hepatocytes. A study with the bile acid taurocholic acid, the uncharged ouabain and the organic cations vecuronium and rocuronium. Biochem Pharmacol 47:2193-2200.
25. int) in a human cell line (HeLa). Pharm Res 14:1316-1321.
26. Sigel E (1990) Use of Xenopus oocytes for the functional expression of plasma membrane proteins. J Membr Biol 117:201-221.
27. Sokol PP and Gates SB (1990) Effect of endogenous and exogenous polyamines on organic cation transport in rabbit renal plasma membrane vesicles. J Pharmacol Exp Ther 255:52-58.
28. Terashita S, Dresser MJ, Zhang L, Gray AT, Yost SC and Giacomini KM (1998) Molecular cloning and functional expression of a rabbit renal organic cation transporter. Biochim Biophys Acta 1369:1-6.
29. Ullrich KJ, Rumrich G, David C and Fritzsch G (1993) Bisubstrates: substances that interact with both, renal contraluminal organic anion and organic cation transport systems. II. Zwitterionic substrates: dipeptides, cephalosporins, quinolone-carboxylate gyrase inhibitors and phosphamide thiazine carboxylates; nonionizable substrates: Steroid hormones and cyclophosphamides. Pflugers Arch 425: 300-312.
30. Valdivieso L, Giacomini KM, Nelson WL, Pershe R and Blaschke TF (1988) Stereo-selective binding of disopyramide to plasma proteins. Pharm Res 5:316-318.
31. Varoqui H, Meunier FM, Meunier FA, Molgo J, Berrard S, Cervini R, Mallet J, Israel M and Diebler MF (1996) Expression of the vesicular acetylcholine transporter in mammalian cells. Prog Brain Res 109:83-95.
32. Wrighton SA and Ring BJ (1994) Inhibition of human CYP3A catalyzed 1′-hydroxymidazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine. Pharm Res 11:921-924.
33. Zhang L, Dresser MJ, Chun JK, Babbitt PC and Giacomini KM (1997a) Cloning and functional characterization of a rat renal organic cation transporter isoform (rOCT1A). J Biol Chem 272:16548-16554.
34. Zhang L, Dresser MJ, Gray AT, Yost SC, Terashita S and Giacomini KM (1997b) Cloning and functional expression of a human liver organic cation transporter. Mol Pharmacol 51:913-921.
35. Zhang L, Brett CM and Giacomini KM (1998) Role of organic cation transporters in drug absorption and elimination. Annu Rev Pharmacol Toxicol 38:431-460.